nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—SLC22A7—Docetaxel—melanoma	0.108	0.343	CbGbCtD
Dinoprostone—CYP1A2—Carmustine—melanoma	0.0862	0.274	CbGbCtD
Dinoprostone—CYP1A2—Vemurafenib—melanoma	0.0681	0.217	CbGbCtD
Dinoprostone—PTGFR—ciliary body—melanoma	0.06	0.365	CbGeAlD
Dinoprostone—CYP1A2—Dacarbazine—melanoma	0.0522	0.166	CbGbCtD
Dinoprostone—SLC22A8—optic choroid—melanoma	0.00785	0.0478	CbGeAlD
Dinoprostone—PTGIR—endothelium—melanoma	0.00585	0.0357	CbGeAlD
Dinoprostone—PTGIR—blood vessel—melanoma	0.0054	0.0329	CbGeAlD
Dinoprostone—ABCC5—hair follicle—melanoma	0.0046	0.0281	CbGeAlD
Dinoprostone—PTGER2—mammalian vulva—melanoma	0.00389	0.0237	CbGeAlD
Dinoprostone—SLCO2A1—neck—melanoma	0.00338	0.0206	CbGeAlD
Dinoprostone—PTGFR—eye—melanoma	0.00326	0.0199	CbGeAlD
Dinoprostone—Disseminated intravascular coagulation—Docetaxel—melanoma	0.00319	0.0265	CcSEcCtD
Dinoprostone—HPGDS—mammalian vulva—melanoma	0.0028	0.017	CbGeAlD
Dinoprostone—PTGER4—head—melanoma	0.00273	0.0167	CbGeAlD
Dinoprostone—SLC51A—head—melanoma	0.00269	0.0164	CbGeAlD
Dinoprostone—PTGER1—head—melanoma	0.00264	0.0161	CbGeAlD
Dinoprostone—SLCO3A1—retina—melanoma	0.00251	0.0153	CbGeAlD
Dinoprostone—SLCO2A1—eye—melanoma	0.00251	0.0153	CbGeAlD
Dinoprostone—Chest tightness—Docetaxel—melanoma	0.00243	0.0202	CcSEcCtD
Dinoprostone—PTGER3—head—melanoma	0.00232	0.0141	CbGeAlD
Dinoprostone—SLCO4A1—retina—melanoma	0.00229	0.014	CbGeAlD
Dinoprostone—ABCC5—retina—melanoma	0.00228	0.0139	CbGeAlD
Dinoprostone—SLCO2A1—skin of body—melanoma	0.00219	0.0133	CbGeAlD
Dinoprostone—SLCO3A1—mammalian vulva—melanoma	0.00201	0.0123	CbGeAlD
Dinoprostone—HPGDS—head—melanoma	0.002	0.0122	CbGeAlD
Dinoprostone—SLCO2A1—mammalian vulva—melanoma	0.00199	0.0121	CbGeAlD
Dinoprostone—Wheezing—Bleomycin—melanoma	0.00197	0.0164	CcSEcCtD
Dinoprostone—PTGER2—lymph node—melanoma	0.00195	0.0119	CbGeAlD
Dinoprostone—PTGER4—lymph node—melanoma	0.00191	0.0117	CbGeAlD
Dinoprostone—SLC51A—lymph node—melanoma	0.00188	0.0115	CbGeAlD
Dinoprostone—PTGFR—head—melanoma	0.00185	0.0113	CbGeAlD
Dinoprostone—SLCO4A1—mammalian vulva—melanoma	0.00183	0.0112	CbGeAlD
Dinoprostone—Hearing impaired—Temozolomide—melanoma	0.0018	0.0149	CcSEcCtD
Dinoprostone—Vaginal inflammation—Temozolomide—melanoma	0.00171	0.0142	CcSEcCtD
Dinoprostone—SLCO1C1—head—melanoma	0.00164	0.00997	CbGeAlD
Dinoprostone—PTGIR—head—melanoma	0.00163	0.00994	CbGeAlD
Dinoprostone—PTGER3—lymph node—melanoma	0.00162	0.00988	CbGeAlD
Dinoprostone—Vaginal infection—Temozolomide—melanoma	0.00162	0.0134	CcSEcCtD
Dinoprostone—SLC22A8—eye—melanoma	0.00158	0.00963	CbGeAlD
Dinoprostone—Angiopathy—Vemurafenib—melanoma	0.00153	0.0127	CcSEcCtD
Dinoprostone—Chills—Vemurafenib—melanoma	0.00151	0.0125	CcSEcCtD
Dinoprostone—SLCO3A1—head—melanoma	0.00144	0.00877	CbGeAlD
Dinoprostone—SLCO2A1—head—melanoma	0.00143	0.00869	CbGeAlD
Dinoprostone—Eye pain—Carmustine—melanoma	0.00142	0.0118	CcSEcCtD
Dinoprostone—Back pain—Vemurafenib—melanoma	0.00142	0.0118	CcSEcCtD
Dinoprostone—CYP11A1—head—melanoma	0.00141	0.0086	CbGeAlD
Dinoprostone—HPGDS—lymph node—melanoma	0.0014	0.00854	CbGeAlD
Dinoprostone—Deafness—Temozolomide—melanoma	0.00139	0.0115	CcSEcCtD
Dinoprostone—Eye pain—Temozolomide—melanoma	0.00138	0.0114	CcSEcCtD
Dinoprostone—Hot flush—Temozolomide—melanoma	0.00133	0.011	CcSEcCtD
Dinoprostone—Menopausal symptoms—Temozolomide—melanoma	0.00132	0.0109	CcSEcCtD
Dinoprostone—SLCO4A1—head—melanoma	0.00131	0.00799	CbGeAlD
Dinoprostone—PTGFR—lymph node—melanoma	0.0013	0.0079	CbGeAlD
Dinoprostone—Chest discomfort—Docetaxel—melanoma	0.00129	0.0107	CcSEcCtD
Dinoprostone—Cough—Vemurafenib—melanoma	0.00128	0.0106	CcSEcCtD
Dinoprostone—Bronchospasm—Bleomycin—melanoma	0.00125	0.0104	CcSEcCtD
Dinoprostone—Arthralgia—Vemurafenib—melanoma	0.00125	0.0104	CcSEcCtD
Dinoprostone—Myalgia—Vemurafenib—melanoma	0.00125	0.0104	CcSEcCtD
Dinoprostone—Hearing impaired—Docetaxel—melanoma	0.0012	0.00994	CcSEcCtD
Dinoprostone—Anaphylactic shock—Vemurafenib—melanoma	0.00119	0.00993	CcSEcCtD
Dinoprostone—Inflammation—Docetaxel—melanoma	0.00117	0.00975	CcSEcCtD
Dinoprostone—Dehydration—Temozolomide—melanoma	0.00116	0.0096	CcSEcCtD
Dinoprostone—SLCO1C1—lymph node—melanoma	0.00115	0.00698	CbGeAlD
Dinoprostone—PTGIR—lymph node—melanoma	0.00114	0.00696	CbGeAlD
Dinoprostone—Acute coronary syndrome—Bleomycin—melanoma	0.00112	0.0093	CcSEcCtD
Dinoprostone—Hypotension—Vemurafenib—melanoma	0.00112	0.00928	CcSEcCtD
Dinoprostone—Myocardial infarction—Bleomycin—melanoma	0.00111	0.00925	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00109	0.00905	CcSEcCtD
Dinoprostone—Sweating increased—Temozolomide—melanoma	0.00105	0.00869	CcSEcCtD
Dinoprostone—SLCO2B1—head—melanoma	0.00102	0.00622	CbGeAlD
Dinoprostone—SLCO3A1—lymph node—melanoma	0.00101	0.00614	CbGeAlD
Dinoprostone—SLCO2A1—lymph node—melanoma	0.000998	0.00608	CbGeAlD
Dinoprostone—CYP11A1—lymph node—melanoma	0.000988	0.00602	CbGeAlD
Dinoprostone—SLC22A1—head—melanoma	0.000975	0.00594	CbGeAlD
Dinoprostone—Flushing—Bleomycin—melanoma	0.000946	0.00786	CcSEcCtD
Dinoprostone—Body temperature increased—Vemurafenib—melanoma	0.000945	0.00785	CcSEcCtD
Dinoprostone—Pharyngitis—Dactinomycin—melanoma	0.000943	0.00784	CcSEcCtD
Dinoprostone—SLCO1A2—head—melanoma	0.000939	0.00572	CbGeAlD
Dinoprostone—Deafness—Docetaxel—melanoma	0.000924	0.00768	CcSEcCtD
Dinoprostone—SLCO4A1—lymph node—melanoma	0.000918	0.0056	CbGeAlD
Dinoprostone—CYP19A1—head—melanoma	0.000917	0.00559	CbGeAlD
Dinoprostone—Chills—Bleomycin—melanoma	0.000914	0.0076	CcSEcCtD
Dinoprostone—ABCC5—lymph node—melanoma	0.000913	0.00556	CbGeAlD
Dinoprostone—ABCC4—head—melanoma	0.000904	0.00551	CbGeAlD
Dinoprostone—SLC22A8—head—melanoma	0.000897	0.00547	CbGeAlD
Dinoprostone—Hot flush—Docetaxel—melanoma	0.000883	0.00734	CcSEcCtD
Dinoprostone—Flushing—Dactinomycin—melanoma	0.000882	0.00733	CcSEcCtD
Dinoprostone—Hypersensitivity—Vemurafenib—melanoma	0.00088	0.00732	CcSEcCtD
Dinoprostone—Menopausal symptoms—Docetaxel—melanoma	0.000876	0.00728	CcSEcCtD
Dinoprostone—Asthenia—Vemurafenib—melanoma	0.000857	0.00713	CcSEcCtD
Dinoprostone—Pharyngitis—Temozolomide—melanoma	0.000853	0.00709	CcSEcCtD
Dinoprostone—Chills—Dactinomycin—melanoma	0.000853	0.00709	CcSEcCtD
Dinoprostone—Flushing—Carmustine—melanoma	0.000826	0.00686	CcSEcCtD
Dinoprostone—Diarrhoea—Vemurafenib—melanoma	0.000818	0.0068	CcSEcCtD
Dinoprostone—Flushing—Temozolomide—melanoma	0.000798	0.00663	CcSEcCtD
Dinoprostone—Arrhythmia—Carmustine—melanoma	0.000795	0.0066	CcSEcCtD
Dinoprostone—Dizziness—Vemurafenib—melanoma	0.00079	0.00657	CcSEcCtD
Dinoprostone—Angiopathy—Temozolomide—melanoma	0.00078	0.00648	CcSEcCtD
Dinoprostone—Immune system disorder—Temozolomide—melanoma	0.000776	0.00645	CcSEcCtD
Dinoprostone—Cough—Bleomycin—melanoma	0.000774	0.00643	CcSEcCtD
Dinoprostone—Chills—Temozolomide—melanoma	0.000771	0.00641	CcSEcCtD
Dinoprostone—Dehydration—Docetaxel—melanoma	0.000768	0.00639	CcSEcCtD
Dinoprostone—Vomiting—Vemurafenib—melanoma	0.00076	0.00631	CcSEcCtD
Dinoprostone—Chest pain—Bleomycin—melanoma	0.000755	0.00628	CcSEcCtD
Dinoprostone—Myalgia—Bleomycin—melanoma	0.000755	0.00628	CcSEcCtD
Dinoprostone—Rash—Vemurafenib—melanoma	0.000753	0.00626	CcSEcCtD
Dinoprostone—Dermatitis—Vemurafenib—melanoma	0.000753	0.00626	CcSEcCtD
Dinoprostone—Back pain—Carmustine—melanoma	0.000749	0.00623	CcSEcCtD
Dinoprostone—Headache—Vemurafenib—melanoma	0.000749	0.00622	CcSEcCtD
Dinoprostone—Cramp muscle—Docetaxel—melanoma	0.000744	0.00618	CcSEcCtD
Dinoprostone—Vision blurred—Carmustine—melanoma	0.00073	0.00607	CcSEcCtD
Dinoprostone—Tremor—Carmustine—melanoma	0.000725	0.00603	CcSEcCtD
Dinoprostone—Anaphylactic shock—Bleomycin—melanoma	0.000724	0.00602	CcSEcCtD
Dinoprostone—Back pain—Temozolomide—melanoma	0.000724	0.00602	CcSEcCtD
Dinoprostone—SLCO2B1—lymph node—melanoma	0.000715	0.00436	CbGeAlD
Dinoprostone—Nausea—Vemurafenib—melanoma	0.00071	0.0059	CcSEcCtD
Dinoprostone—Vision blurred—Temozolomide—melanoma	0.000705	0.00586	CcSEcCtD
Dinoprostone—Myalgia—Dactinomycin—melanoma	0.000704	0.00585	CcSEcCtD
Dinoprostone—Bronchospasm—Docetaxel—melanoma	0.000702	0.00584	CcSEcCtD
Dinoprostone—Tremor—Temozolomide—melanoma	0.000701	0.00583	CcSEcCtD
Dinoprostone—Hypotension—Bleomycin—melanoma	0.000677	0.00562	CcSEcCtD
Dinoprostone—Hypertension—Carmustine—melanoma	0.000669	0.00556	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Bleomycin—melanoma	0.00066	0.00548	CcSEcCtD
Dinoprostone—Chest pain—Carmustine—melanoma	0.000659	0.00548	CcSEcCtD
Dinoprostone—Myalgia—Carmustine—melanoma	0.000659	0.00548	CcSEcCtD
Dinoprostone—Cough—Temozolomide—melanoma	0.000653	0.00543	CcSEcCtD
Dinoprostone—Paraesthesia—Bleomycin—melanoma	0.00065	0.0054	CcSEcCtD
Dinoprostone—Hypertension—Temozolomide—melanoma	0.000646	0.00537	CcSEcCtD
Dinoprostone—Dyspnoea—Bleomycin—melanoma	0.000645	0.00536	CcSEcCtD
Dinoprostone—CYP19A1—lymph node—melanoma	0.000642	0.00391	CbGeAlD
Dinoprostone—Arthralgia—Temozolomide—melanoma	0.000637	0.00529	CcSEcCtD
Dinoprostone—Myalgia—Temozolomide—melanoma	0.000637	0.00529	CcSEcCtD
Dinoprostone—ABCC4—lymph node—melanoma	0.000633	0.00386	CbGeAlD
Dinoprostone—Acute coronary syndrome—Docetaxel—melanoma	0.000628	0.00522	CcSEcCtD
Dinoprostone—Myocardial infarction—Docetaxel—melanoma	0.000624	0.00519	CcSEcCtD
Dinoprostone—Pain—Bleomycin—melanoma	0.000619	0.00515	CcSEcCtD
Dinoprostone—Tachycardia—Carmustine—melanoma	0.000617	0.00513	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000615	0.00511	CcSEcCtD
Dinoprostone—Anaphylactic shock—Temozolomide—melanoma	0.000611	0.00508	CcSEcCtD
Dinoprostone—Hypotension—Carmustine—melanoma	0.000591	0.00491	CcSEcCtD
Dinoprostone—Hyperhidrosis—Temozolomide—melanoma	0.00059	0.00491	CcSEcCtD
Dinoprostone—Pain—Dactinomycin—melanoma	0.000577	0.0048	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Carmustine—melanoma	0.000576	0.00479	CcSEcCtD
Dinoprostone—Body temperature increased—Bleomycin—melanoma	0.000572	0.00476	CcSEcCtD
Dinoprostone—Paraesthesia—Carmustine—melanoma	0.000567	0.00472	CcSEcCtD
Dinoprostone—Pharyngitis—Docetaxel—melanoma	0.000567	0.00472	CcSEcCtD
Dinoprostone—Dyspnoea—Carmustine—melanoma	0.000563	0.00468	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Temozolomide—melanoma	0.000556	0.00462	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Dactinomycin—melanoma	0.000552	0.00459	CcSEcCtD
Dinoprostone—Paraesthesia—Temozolomide—melanoma	0.000548	0.00456	CcSEcCtD
Dinoprostone—Dyspnoea—Temozolomide—melanoma	0.000544	0.00453	CcSEcCtD
Dinoprostone—Pain—Carmustine—melanoma	0.00054	0.00449	CcSEcCtD
Dinoprostone—Body temperature increased—Dactinomycin—melanoma	0.000534	0.00444	CcSEcCtD
Dinoprostone—Abdominal pain—Dactinomycin—melanoma	0.000534	0.00444	CcSEcCtD
Dinoprostone—Hypersensitivity—Bleomycin—melanoma	0.000533	0.00443	CcSEcCtD
Dinoprostone—Flushing—Docetaxel—melanoma	0.000531	0.00441	CcSEcCtD
Dinoprostone—Pain—Temozolomide—melanoma	0.000522	0.00434	CcSEcCtD
Dinoprostone—Asthenia—Bleomycin—melanoma	0.000519	0.00432	CcSEcCtD
Dinoprostone—Angiopathy—Docetaxel—melanoma	0.000519	0.00431	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Carmustine—melanoma	0.000517	0.0043	CcSEcCtD
Dinoprostone—Immune system disorder—Docetaxel—melanoma	0.000516	0.00429	CcSEcCtD
Dinoprostone—Chills—Docetaxel—melanoma	0.000513	0.00426	CcSEcCtD
Dinoprostone—Arrhythmia—Docetaxel—melanoma	0.000511	0.00424	CcSEcCtD
Dinoprostone—Abdominal pain—Carmustine—melanoma	0.0005	0.00415	CcSEcCtD
Dinoprostone—Body temperature increased—Carmustine—melanoma	0.0005	0.00415	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Temozolomide—melanoma	0.000499	0.00415	CcSEcCtD
Dinoprostone—Hypersensitivity—Dactinomycin—melanoma	0.000497	0.00413	CcSEcCtD
Dinoprostone—Asthenia—Dactinomycin—melanoma	0.000484	0.00403	CcSEcCtD
Dinoprostone—Abdominal pain—Temozolomide—melanoma	0.000483	0.00401	CcSEcCtD
Dinoprostone—Body temperature increased—Temozolomide—melanoma	0.000483	0.00401	CcSEcCtD
Dinoprostone—Back pain—Docetaxel—melanoma	0.000481	0.004	CcSEcCtD
Dinoprostone—Muscle spasms—Docetaxel—melanoma	0.000478	0.00398	CcSEcCtD
Dinoprostone—Hypersensitivity—Carmustine—melanoma	0.000466	0.00387	CcSEcCtD
Dinoprostone—Diarrhoea—Dactinomycin—melanoma	0.000462	0.00384	CcSEcCtD
Dinoprostone—Vomiting—Bleomycin—melanoma	0.00046	0.00383	CcSEcCtD
Dinoprostone—Rash—Bleomycin—melanoma	0.000456	0.00379	CcSEcCtD
Dinoprostone—Dermatitis—Bleomycin—melanoma	0.000456	0.00379	CcSEcCtD
Dinoprostone—Asthenia—Carmustine—melanoma	0.000453	0.00377	CcSEcCtD
Dinoprostone—Hypersensitivity—Temozolomide—melanoma	0.00045	0.00374	CcSEcCtD
Dinoprostone—Syncope—Docetaxel—melanoma	0.000446	0.00371	CcSEcCtD
Dinoprostone—Asthenia—Temozolomide—melanoma	0.000438	0.00364	CcSEcCtD
Dinoprostone—Loss of consciousness—Docetaxel—melanoma	0.000437	0.00364	CcSEcCtD
Dinoprostone—Cough—Docetaxel—melanoma	0.000434	0.00361	CcSEcCtD
Dinoprostone—Diarrhoea—Carmustine—melanoma	0.000432	0.00359	CcSEcCtD
Dinoprostone—Nausea—Bleomycin—melanoma	0.00043	0.00357	CcSEcCtD
Dinoprostone—Hypertension—Docetaxel—melanoma	0.00043	0.00357	CcSEcCtD
Dinoprostone—Vomiting—Dactinomycin—melanoma	0.000429	0.00357	CcSEcCtD
Dinoprostone—Rash—Dactinomycin—melanoma	0.000426	0.00354	CcSEcCtD
Dinoprostone—Chest pain—Docetaxel—melanoma	0.000424	0.00352	CcSEcCtD
Dinoprostone—Myalgia—Docetaxel—melanoma	0.000424	0.00352	CcSEcCtD
Dinoprostone—Arthralgia—Docetaxel—melanoma	0.000424	0.00352	CcSEcCtD
Dinoprostone—Dizziness—Carmustine—melanoma	0.000418	0.00347	CcSEcCtD
Dinoprostone—Diarrhoea—Temozolomide—melanoma	0.000418	0.00347	CcSEcCtD
Dinoprostone—Anaphylactic shock—Docetaxel—melanoma	0.000406	0.00338	CcSEcCtD
Dinoprostone—Dizziness—Temozolomide—melanoma	0.000404	0.00336	CcSEcCtD
Dinoprostone—Vomiting—Carmustine—melanoma	0.000402	0.00334	CcSEcCtD
Dinoprostone—Nausea—Dactinomycin—melanoma	0.000401	0.00333	CcSEcCtD
Dinoprostone—Shock—Docetaxel—melanoma	0.0004	0.00332	CcSEcCtD
Dinoprostone—Rash—Carmustine—melanoma	0.000398	0.00331	CcSEcCtD
Dinoprostone—Dermatitis—Carmustine—melanoma	0.000398	0.00331	CcSEcCtD
Dinoprostone—Tachycardia—Docetaxel—melanoma	0.000396	0.00329	CcSEcCtD
Dinoprostone—Headache—Carmustine—melanoma	0.000396	0.00329	CcSEcCtD
Dinoprostone—Vomiting—Temozolomide—melanoma	0.000388	0.00323	CcSEcCtD
Dinoprostone—Rash—Temozolomide—melanoma	0.000385	0.0032	CcSEcCtD
Dinoprostone—Dermatitis—Temozolomide—melanoma	0.000385	0.0032	CcSEcCtD
Dinoprostone—Headache—Temozolomide—melanoma	0.000383	0.00318	CcSEcCtD
Dinoprostone—Hypotension—Docetaxel—melanoma	0.000379	0.00315	CcSEcCtD
Dinoprostone—Nausea—Carmustine—melanoma	0.000375	0.00312	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Docetaxel—melanoma	0.00037	0.00308	CcSEcCtD
Dinoprostone—Paraesthesia—Docetaxel—melanoma	0.000365	0.00303	CcSEcCtD
Dinoprostone—Nausea—Temozolomide—melanoma	0.000363	0.00302	CcSEcCtD
Dinoprostone—Dyspnoea—Docetaxel—melanoma	0.000362	0.00301	CcSEcCtD
Dinoprostone—Pain—Docetaxel—melanoma	0.000347	0.00289	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Docetaxel—melanoma	0.000332	0.00276	CcSEcCtD
Dinoprostone—Abdominal pain—Docetaxel—melanoma	0.000321	0.00267	CcSEcCtD
Dinoprostone—Body temperature increased—Docetaxel—melanoma	0.000321	0.00267	CcSEcCtD
Dinoprostone—Hypersensitivity—Docetaxel—melanoma	0.000299	0.00249	CcSEcCtD
Dinoprostone—Asthenia—Docetaxel—melanoma	0.000291	0.00242	CcSEcCtD
Dinoprostone—Diarrhoea—Docetaxel—melanoma	0.000278	0.00231	CcSEcCtD
Dinoprostone—Dizziness—Docetaxel—melanoma	0.000269	0.00223	CcSEcCtD
Dinoprostone—Vomiting—Docetaxel—melanoma	0.000258	0.00215	CcSEcCtD
Dinoprostone—Rash—Docetaxel—melanoma	0.000256	0.00213	CcSEcCtD
Dinoprostone—Dermatitis—Docetaxel—melanoma	0.000256	0.00213	CcSEcCtD
Dinoprostone—Headache—Docetaxel—melanoma	0.000254	0.00211	CcSEcCtD
Dinoprostone—Nausea—Docetaxel—melanoma	0.000241	0.00201	CcSEcCtD
Dinoprostone—SLCO1A2—Metabolism—ERCC2—melanoma	1.69e-05	4.2e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CTNNB1—melanoma	1.68e-05	4.19e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ABCB1—melanoma	1.67e-05	4.16e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—HRAS—melanoma	1.67e-05	4.16e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—PIK3CA—melanoma	1.66e-05	4.13e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—VEGFA—melanoma	1.65e-05	4.11e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CDKN1A—melanoma	1.64e-05	4.1e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—melanoma	1.64e-05	4.09e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MYC—melanoma	1.64e-05	4.09e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PTEN—melanoma	1.64e-05	4.09e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP1B1—melanoma	1.64e-05	4.08e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—STAT3—melanoma	1.63e-05	4.07e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—PIK3CA—melanoma	1.63e-05	4.06e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—NRAS—melanoma	1.63e-05	4.06e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MDM2—melanoma	1.62e-05	4.04e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MAPK1—melanoma	1.61e-05	4.01e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—EGFR—melanoma	1.61e-05	4e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—melanoma	1.6e-05	3.99e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ERBB2—melanoma	1.6e-05	3.99e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CD—melanoma	1.6e-05	3.98e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—PIK3CA—melanoma	1.59e-05	3.97e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—PIK3CA—melanoma	1.59e-05	3.97e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PIK3CB—melanoma	1.59e-05	3.96e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MDM2—melanoma	1.59e-05	3.96e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MDM2—melanoma	1.59e-05	3.96e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ABCB1—melanoma	1.58e-05	3.94e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PIK3CB—melanoma	1.58e-05	3.93e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ALB—melanoma	1.58e-05	3.93e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTGS2—melanoma	1.57e-05	3.92e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—HRAS—melanoma	1.57e-05	3.92e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LUM—melanoma	1.57e-05	3.91e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PHGDH—melanoma	1.57e-05	3.91e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ERBB2—melanoma	1.57e-05	3.9e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ERBB2—melanoma	1.57e-05	3.9e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MAPK3—melanoma	1.56e-05	3.89e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PIK3CB—melanoma	1.55e-05	3.85e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PIK3CB—melanoma	1.55e-05	3.85e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HPSE—melanoma	1.54e-05	3.84e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PRKCA—melanoma	1.54e-05	3.83e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—HRAS—melanoma	1.53e-05	3.82e-05	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—AKT1—melanoma	1.53e-05	3.81e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ERCC2—melanoma	1.52e-05	3.8e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—KRAS—melanoma	1.52e-05	3.78e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CXCL8—melanoma	1.52e-05	3.78e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MYC—melanoma	1.52e-05	3.78e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CUBN—melanoma	1.51e-05	3.77e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—HRAS—melanoma	1.51e-05	3.76e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6—melanoma	1.5e-05	3.75e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CXCL8—melanoma	1.48e-05	3.7e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CXCL8—melanoma	1.48e-05	3.7e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MAPK1—melanoma	1.48e-05	3.7e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EGFR—melanoma	1.48e-05	3.7e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN1B—melanoma	1.48e-05	3.69e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—HRAS—melanoma	1.48e-05	3.68e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—HRAS—melanoma	1.48e-05	3.68e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—STAT3—melanoma	1.47e-05	3.66e-05	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—AKT1—melanoma	1.47e-05	3.65e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—NRAS—melanoma	1.46e-05	3.65e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SDHD—melanoma	1.46e-05	3.64e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CSPG4—melanoma	1.46e-05	3.64e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—BSG—melanoma	1.46e-05	3.64e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PRKCA—melanoma	1.45e-05	3.62e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CASP3—melanoma	1.45e-05	3.62e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN1B—melanoma	1.45e-05	3.61e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN1B—melanoma	1.45e-05	3.61e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL2—melanoma	1.45e-05	3.61e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ABCB1—melanoma	1.45e-05	3.61e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—melanoma	1.44e-05	3.6e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ERCC2—melanoma	1.44e-05	3.59e-05	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—AKT1—melanoma	1.43e-05	3.58e-05	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—AKT1—melanoma	1.43e-05	3.58e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CASP3—melanoma	1.42e-05	3.54e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CASP3—melanoma	1.42e-05	3.54e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL2—melanoma	1.42e-05	3.54e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL2—melanoma	1.42e-05	3.54e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCND1—melanoma	1.41e-05	3.52e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GPAM—melanoma	1.41e-05	3.52e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—melanoma	1.41e-05	3.52e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—melanoma	1.41e-05	3.52e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MAPK3—melanoma	1.4e-05	3.49e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KRAS—melanoma	1.4e-05	3.49e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CTNNB1—melanoma	1.4e-05	3.49e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.4e-05	3.48e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PIK3CA—melanoma	1.39e-05	3.48e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CB—melanoma	1.39e-05	3.47e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—AKT1—melanoma	1.39e-05	3.46e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCND1—melanoma	1.38e-05	3.45e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCND1—melanoma	1.38e-05	3.45e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—melanoma	1.38e-05	3.44e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTEN—melanoma	1.37e-05	3.42e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP9—melanoma	1.37e-05	3.42e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CTNNB1—melanoma	1.37e-05	3.41e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CTNNB1—melanoma	1.37e-05	3.41e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN1A—melanoma	1.37e-05	3.41e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PTEN—melanoma	1.36e-05	3.4e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—melanoma	1.36e-05	3.4e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NFKB1—melanoma	1.36e-05	3.38e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—AKT1—melanoma	1.35e-05	3.37e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—melanoma	1.35e-05	3.36e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ABCB1—melanoma	1.35e-05	3.36e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP9—melanoma	1.34e-05	3.35e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP9—melanoma	1.34e-05	3.35e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN1A—melanoma	1.34e-05	3.34e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN1A—melanoma	1.34e-05	3.34e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PTEN—melanoma	1.34e-05	3.33e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PTEN—melanoma	1.34e-05	3.33e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MAPK1—melanoma	1.33e-05	3.32e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EGFR—melanoma	1.33e-05	3.32e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PRKCA—melanoma	1.33e-05	3.32e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CG—melanoma	1.33e-05	3.32e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—AKT1—melanoma	1.33e-05	3.32e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NFKB1—melanoma	1.33e-05	3.31e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NFKB1—melanoma	1.33e-05	3.31e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ERCC2—melanoma	1.32e-05	3.29e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—AKT1—melanoma	1.3e-05	3.25e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—AKT1—melanoma	1.3e-05	3.25e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HRAS—melanoma	1.29e-05	3.22e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PIK3CA—melanoma	1.29e-05	3.21e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PPARG—melanoma	1.28e-05	3.2e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.26e-05	3.15e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—KRAS—melanoma	1.26e-05	3.14e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—melanoma	1.25e-05	3.1e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PRKCA—melanoma	1.24e-05	3.09e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—melanoma	1.23e-05	3.08e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—melanoma	1.23e-05	3.07e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ERCC2—melanoma	1.23e-05	3.07e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—STAT3—melanoma	1.22e-05	3.04e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NRAS—melanoma	1.22e-05	3.03e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—melanoma	1.21e-05	3.01e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—melanoma	1.21e-05	3.01e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CG—melanoma	1.2e-05	3e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTEN—melanoma	1.2e-05	3e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PLA2G6—melanoma	1.2e-05	2.99e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—STAT3—melanoma	1.19e-05	2.98e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—STAT3—melanoma	1.19e-05	2.98e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.19e-05	2.98e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NRAS—melanoma	1.19e-05	2.97e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NRAS—melanoma	1.19e-05	2.97e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HRAS—melanoma	1.19e-05	2.97e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CD—melanoma	1.17e-05	2.92e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK3—melanoma	1.17e-05	2.91e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PPARG—melanoma	1.16e-05	2.89e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PIK3CA—melanoma	1.16e-05	2.88e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ALB—melanoma	1.16e-05	2.88e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK3—melanoma	1.14e-05	2.84e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK3—melanoma	1.14e-05	2.84e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—melanoma	1.14e-05	2.84e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—AKT1—melanoma	1.14e-05	2.84e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CG—melanoma	1.14e-05	2.84e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—melanoma	1.13e-05	2.83e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—melanoma	1.11e-05	2.77e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—melanoma	1.11e-05	2.77e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK1—melanoma	1.11e-05	2.76e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EGFR—melanoma	1.11e-05	2.76e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPARG—melanoma	1.1e-05	2.74e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK1—melanoma	1.09e-05	2.71e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK1—melanoma	1.09e-05	2.71e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EGFR—melanoma	1.09e-05	2.71e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EGFR—melanoma	1.09e-05	2.71e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—VCAN—melanoma	1.08e-05	2.69e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HRAS—melanoma	1.07e-05	2.67e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CD—melanoma	1.06e-05	2.64e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—AKT1—melanoma	1.05e-05	2.62e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KRAS—melanoma	1.05e-05	2.61e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ALB—melanoma	1.04e-05	2.6e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CG—melanoma	1.04e-05	2.6e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KRAS—melanoma	1.03e-05	2.56e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KRAS—melanoma	1.03e-05	2.56e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—melanoma	1.02e-05	2.55e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.02e-05	2.55e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CB—melanoma	1.02e-05	2.54e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—melanoma	1.01e-05	2.52e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPARG—melanoma	1.01e-05	2.51e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CD—melanoma	1e-05	2.49e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ALB—melanoma	9.88e-06	2.46e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.86e-06	2.46e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CG—melanoma	9.72e-06	2.42e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PIK3CA—melanoma	9.69e-06	2.41e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PIK3CA—melanoma	9.62e-06	2.4e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—AKT1—melanoma	9.45e-06	2.36e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PIK3CA—melanoma	9.42e-06	2.35e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PIK3CA—melanoma	9.42e-06	2.35e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPARG—melanoma	9.39e-06	2.34e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—melanoma	9.31e-06	2.32e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CB—melanoma	9.22e-06	2.3e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CD—melanoma	9.17e-06	2.29e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—melanoma	9.14e-06	2.28e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—melanoma	9.11e-06	2.27e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—melanoma	9.11e-06	2.27e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP17A1—melanoma	9.11e-06	2.27e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ALB—melanoma	9.05e-06	2.26e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.98e-06	2.24e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HRAS—melanoma	8.9e-06	2.22e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	8.87e-06	2.21e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTEN—melanoma	8.82e-06	2.2e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CB—melanoma	8.72e-06	2.17e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HRAS—melanoma	8.72e-06	2.17e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HRAS—melanoma	8.72e-06	2.17e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—melanoma	8.64e-06	2.15e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GNA11—melanoma	8.6e-06	2.14e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CD—melanoma	8.55e-06	2.13e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—melanoma	8.52e-06	2.12e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CA—melanoma	8.48e-06	2.11e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ALB—melanoma	8.44e-06	2.1e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—FASN—melanoma	8.42e-06	2.1e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—melanoma	8.34e-06	2.08e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—melanoma	8.34e-06	2.08e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC5A5—melanoma	8.28e-06	2.06e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GNAQ—melanoma	7.99e-06	1.99e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CD44—melanoma	7.99e-06	1.99e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CB—melanoma	7.99e-06	1.99e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTEN—melanoma	7.97e-06	1.99e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—melanoma	7.92e-06	1.97e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—AKT1—melanoma	7.91e-06	1.97e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—AKT1—melanoma	7.86e-06	1.96e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.83e-06	1.95e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.76e-06	1.93e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—AKT1—melanoma	7.7e-06	1.92e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—AKT1—melanoma	7.7e-06	1.92e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP1B1—melanoma	7.66e-06	1.91e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTEN—melanoma	7.54e-06	1.88e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CB—melanoma	7.45e-06	1.86e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—melanoma	7.38e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—AKT1—melanoma	6.93e-06	1.73e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTEN—melanoma	6.91e-06	1.72e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.76e-06	1.69e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTEN—melanoma	6.44e-06	1.6e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCB1—melanoma	6.31e-06	1.57e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CA—melanoma	6.22e-06	1.55e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PRKCA—melanoma	5.81e-06	1.45e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ERCC2—melanoma	5.76e-06	1.44e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CA—melanoma	5.62e-06	1.4e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CA—melanoma	5.32e-06	1.33e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AKT1—melanoma	5.08e-06	1.27e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CA—melanoma	4.87e-06	1.21e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.77e-06	1.19e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKT1—melanoma	4.59e-06	1.14e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CG—melanoma	4.55e-06	1.13e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CA—melanoma	4.54e-06	1.13e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARG—melanoma	4.39e-06	1.09e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKT1—melanoma	4.34e-06	1.08e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CD—melanoma	4e-06	9.97e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKT1—melanoma	3.98e-06	9.92e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALB—melanoma	3.95e-06	9.84e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKT1—melanoma	3.71e-06	9.25e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CB—melanoma	3.49e-06	8.69e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—melanoma	3.45e-06	8.61e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTEN—melanoma	3.01e-06	7.51e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CA—melanoma	2.13e-06	5.3e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKT1—melanoma	1.74e-06	4.33e-06	CbGpPWpGaD
